13D Filing: Elliott Associates, L.P. and Mednax Inc. (MD)

Page 3 of 11

Page 3 of 11 – SEC Filing

1

NAME OF REPORTING PERSON

Elliott International, L.P.

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) x

(b) ¨

3 SEC USE ONLY
4

SOURCE OF FUNDS

WC

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands, British West Indies

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7

SOLE VOTING POWER

0

8

SHARED VOTING POWER

1,292,000 (1)

9

SOLE DISPOSITIVE POWER

0

10

SHARED DISPOSITIVE POWER

1,292,000 (1)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,292,000 (1)

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.4%

14

TYPE OF REPORTING PERSON

PN

(1) Excludes cash-settled swaps disclosed in Item 5 representing
economic exposure comparable to 3,179,001 additional shares of Common Stock (as defined below), which if aggregated with such beneficially
owned shares, represent an aggregate economic interest in 4,471,001 shares representing of 4.8% of the outstanding shares.

Follow Pediatrix Medical Group Inc. (NYSE:MD)

Page 3 of 11